MCID: PYR010
MIFTS: 52

Peyronie's Disease malady

Categories: Rare diseases, Reproductive diseases

Aliases & Classifications for Peyronie's Disease

About this section
Sources:
33MalaCards, 10Disease Ontology, 12DISEASES, 65UMLS, 45NIH Rare Diseases, 47Novoseek, 36MeSH, 27ICD10, 29ICD9CM, 42NCIt, 59SNOMED-CT
See all MalaCards sources

Aliases & Descriptions for Peyronie's Disease:

Name: Peyronie's Disease 33 10 12
Peyronie Disease 10 45 47 65
Balanitis Xerotica Obliterans 65
Induratio Penis Plastica 10
 
Peyronie's Fibromatosis 10
Penile Induration 36
Peyronies Disease 33
Penile Curvature 45

Classifications:



External Ids:

Disease Ontology10 DOID:8616
ICD1027 N48.6
ICD9CM29 607.85
MeSH36 D010411
NCIt42 C3316
UMLS65 C0030848

Summaries for Peyronie's Disease

About this section
NIH Rare Diseases:45 Peyronie disease is a connective tissue disorder characterized by a plaque, or hard lump, that forms within the penis. affected individuals may experience painful, curved erections which can make make normal sexual intercourse impossible. symptoms may appear suddenly or develop gradually. while the painful erections for most men resolve over time, the scar tissue and curvature may remain. some cases appear to resolve spontaneously. the exact cause of peyronie's disease is not known. last updated: 11/23/2011

MalaCards based summary: Peyronie's Disease, also known as peyronie disease, is related to keratoconus and listeria meningitis, and has symptoms including abnormality of the skeletal system, abnormality of the genitourinary system and edema of penis. An important gene associated with Peyronie's Disease is IFNA2 (Interferon, Alpha 2), and among its related pathways are Type II interferon signaling (IFNG) and NO-dependent CFTR activation (normal and CF). Affiliated tissues include prostate, kidney and breast, and related mouse phenotype muscle.

Wikipedia:68 Peyronie\'s disease or Peyronie disease (/peɪroʊˈniː/), also known as induratio penis plastica (IPP)... more...

Related Diseases for Peyronie's Disease

About this section

Graphical network of the top 20 diseases related to Peyronie's Disease:



Diseases related to peyronie's disease

Symptoms for Peyronie's Disease

About this section

HPO human phenotypes related to Peyronie's Disease:

id Description Frequency HPO Source Accession
1 abnormality of the skeletal system HP:0000924
2 abnormality of the genitourinary system HP:0000119

UMLS symptoms related to Peyronie's Disease:


edema of penis, penile burning sensation, penile swelling, pain in penis, discharge from penis

Drugs & Therapeutics for Peyronie's Disease

About this section

Drugs for Peyronie's Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 40)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SevelamerapprovedPhase 372152751-57-03085017
Synonyms:
Renagel
Renvela
Sevelamer
Sevelamer Carbonate
 
Sevelamero
Sevelamerum
Sévélamer
sevelamer carbonate
sevelamer hydrochloride
2Chelating AgentsPhase 3667
3
AcetylcholineexperimentalPhase 268951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
4Neurotransmitter AgentsPhase 214795
5OnabotulinumtoxinAPhase 2588
6Peripheral Nervous System AgentsPhase 218510
7Neuromuscular AgentsPhase 2922
8Pharmaceutical SolutionsPhase 27004
9IncobotulinumtoxinAPhase 2599
10AbobotulinumtoxinAPhase 2588
11Botulinum ToxinsPhase 2616
12Botulinum Toxins, Type APhase 2588
13Cholinergic AgentsPhase 23243
14
MethyltestosteroneapprovedPhase 147458-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
15
Testosteroneapproved, investigationalPhase 147458-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
Aveed
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depo-testosterone
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Fortesta
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
Intrinsa
 
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Natesto nasal gel
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Gel
Testosterone Heptanoate
Testosterone Hydrate
Testosterone Propionate
Testosterone Undecanoate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Vogelxo
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
16
Ergocalciferolapproved, nutraceuticalPhase 192350-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
17
Vitamin Eapproved, nutraceuticalPhase 137159-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-alpha-tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'r)-alpha-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-alpha-tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitamin e
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
d-alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
18Testosterone 17 beta-cypionatePhase 1474
19Testosterone undecanoatePhase 1474
20
Testosterone enanthatePhase 1474315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
21Trace ElementsPhase 13900
22VitaminsPhase 13857
23vitamin dPhase 11524
24TocotrienolsPhase 1372
25TocopherolsPhase 1376
26ErgocalciferolsPhase 1923
27MicronutrientsPhase 13901
28Bone Density Conservation AgentsPhase 12600
29Antineoplastic Agents, HormonalPhase 14256
30AndrogensPhase 11162
31Hormone AntagonistsPhase 110002
32Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 19988
33HormonesPhase 111748
34Anabolic AgentsPhase 1375
35Vitamin D2NutraceuticalPhase 1923
36CalciferolNutraceuticalPhase 11074
37TocotrienolNutraceuticalPhase 1372
38TocopherolNutraceuticalPhase 1376
39Phosphodiesterase 5 Inhibitors513
40Mitogens1386

Interventional clinical trials:

(show all 19)
idNameStatusNCT IDPhase
1Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies DiseaseActive, not recruitingNCT02298829Phase 4
2Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221597Phase 3
3A Study of AA4500 in Men With Peyronie's DiseaseCompletedNCT01243411Phase 3
4Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221623Phase 3
5A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's DiseaseCompletedNCT01685437Phase 3
6An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's DiseaseActive, not recruitingNCT02267460Phase 3
7A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTerminatedNCT00833768Phase 3
8The Safety and Effectiveness of AA4500 in Subjects With Peyronie's DiseaseCompletedNCT00755222Phase 2
9Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's DiseaseCompletedNCT01430169Phase 2
10H-22411: BOTOX® for Peyronie's DiseaseRecruitingNCT00812838Phase 2
11Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)RecruitingNCT01184586Phase 2
12Peyronie's Disease Treatment ProtocolCompletedNCT02072018Phase 1
13Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PDCompletedNCT02395029Phase 1
14Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's DiseaseActive, not recruitingNCT01578473Phase 1
15Change in Penile Length Following Bilateral Nerve-Sparing Radical ProstatectomyCompletedNCT00800813
16Management of Peyronie's Disease With Adipose Tissue Stem CellRecruitingNCT02414308
17Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary ConditionsRecruitingNCT01953523
18Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014RecruitingNCT01503034
19Efficacy of Extracorporal Shock Wave Therapy in Patient With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain SyndromeActive, not recruitingNCT01714830

Search NIH Clinical Center for Peyronie's Disease


Cochrane evidence based reviews: penile induration

Genetic Tests for Peyronie's Disease

About this section

Anatomical Context for Peyronie's Disease

About this section

MalaCards organs/tissues related to Peyronie's Disease:

33
Prostate, Kidney, Breast, Small intestine, Endothelial, Bone, T cells

Animal Models for Peyronie's Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Peyronie's Disease:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.0DCN, MSTN, NOS2, SOD1, TGFB1

Publications for Peyronie's Disease

About this section

Articles related to Peyronie's Disease:

(show top 50)    (show all 593)
idTitleAuthorsYear
1
PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT. (26279643)
2015
2
The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease. (25804087)
2015
3
Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie's disease or erectile dysfunction and does not correlate with Peyronie's disease severity. (25580982)
2015
4
Re: Penile Corporoplasty with Yachia's Technique for Peyronie's Disease: Single Center Experience with 117 Patients. (24411890)
2014
5
Psychosexual Symptoms and Treatment of Peyronie's Disease Within a Collaborative Care Model. (25548648)
2014
6
Baseline Characteristics from an Ongoing Phase 3 Study of Collagenase Clostridium Histolyticum in Patients with Peyronie's Disease. (24112401)
2013
7
Surgical therapy of Peyronie's disease by partial plaque excision and grafting with collagen fleece: feasibility study of a new technique. (23446807)
2013
8
Peyronie's disease in Minoan art. (23578389)
2013
9
Penile corporoplasty with Yachia's technique for Peyronie's disease: Single center experience with 117 patients. (24049379)
2013
10
Re: long-term results of the surgical treatment of Peyronie's disease with Egydio's technique: a European multicentre study. (22325532)
2012
11
Update on plication procedures for Peyronie's disease and other penile deformities. (23205060)
2012
12
A new, innovative, lengthening surgical procedure for Peyronie's disease by penile prosthesis implantation with double dorsal-ventral patch graft: the "sliding technique". (22429331)
2012
13
Peyronie's disease: perspectives on therapeutic targets. (21492024)
2011
14
Re: The Role of Vacuum Pump Therapy to Mechanically Straighten the Penis in Peyronie's Disease. (22088643)
2011
15
Imaging modalities and clinical assesment in men affected with Peyronie's disease. (22802839)
2011
16
Risk factors of Peyronie's disease. What does our clinical experience show? (20955309)
2011
17
Inflatable penile prosthesis placement in men with Peyronie's disease and drug-resistant erectile dysfunction: A single-center study. (20722782)
2010
18
Current surgical management of severe peyronie's disease. (21098900)
2010
19
Is there a place for conservative treatment in Peyronie's disease? (19338644)
2009
20
Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study. (19138361)
2009
21
The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease. (18592390)
2009
22
Stereological and biochemical analysis of muscular and connective tissue components in the penile corpus cavernosum adjacent to the fibrous plaque of Peyronie's disease. (18782314)
2009
23
Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study. (18373527)
2008
24
The chronology of depression and distress in men with Peyronie's disease. (18554257)
2008
25
Surgical treatment of Peyronie's disease: choosing the best approach to improve patient satisfaction. (18087656)
2008
26
Experience with plaque excision and dermal grafting in the surgical treatment of Peyronie's disease. (18946615)
2008
27
Risk factors for emotional and relationship problems in Peyronie's disease. (18638001)
2008
28
Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. (17706714)
2007
29
A Survey of primary-care physicians and urologists regarding Peyronie's disease. (17627727)
2007
30
The natural history of Peyronie's disease. (17601314)
2007
31
Surgical therapy of Peyronie's disease. (18219716)
2006
32
Evaluation of post-operative residual function of corpora cavernosa after soft penile prosthesis implant for Peyronie's disease. (16929602)
2006
33
A critical analysis of nonsurgical treatment of Peyronie's disease. (16698449)
2006
34
The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's disease. (15839925)
2005
35
Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease. (15474273)
2004
36
Corporoplasty for advanced Peyronie's disease using venous and/or dermis patch grafting: new surgical technique and long-term patient satisfaction. (12576826)
2003
37
Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease. (14501786)
2003
38
Experience with intraplaque injection of verapamil for Peyronie's disease. (12131321)
2002
39
Management of Peyronie's disease--a review. (11550782)
2001
40
Peyronie's disease in men under age 40: characteristics and outcome. (11313836)
2001
41
Current sexual functioning in 106 patients with Peyronie's disease treated with radiotherapy 9 years earlier. (11113753)
2000
42
The use of betamethasone and hyaluronidase injections in the treatment of Peyronie's disease. (11195899)
2000
43
Microsatellite alterations and loss of heterozygosity in Peyronie's disease. (10953165)
2000
44
Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. (10799165)
2000
45
Saphenous vein harvesting by 'stripping' technique and 'W'-shaped patch covering after plaque incision in treatment of Peyronie's disease. (11416831)
2000
46
Tamoxifen versus placebo in the treatment of Peyronie's disease. (10569556)
1999
47
Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. (9302128)
1997
48
La Peyronie's disease. Our experience]. (2186297)
1990
49
50

Variations for Peyronie's Disease

About this section

Expression for genes affiliated with Peyronie's Disease

About this section
Search GEO for disease gene expression data for Peyronie's Disease.

Pathways for genes affiliated with Peyronie's Disease

About this section

GO Terms for genes affiliated with Peyronie's Disease

About this section

Biological processes related to Peyronie's Disease according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of T cell proliferationGO:004213010.3PDE5A, TGFB1
2positive regulation of MAP kinase activityGO:004340610.2PDE5A, TGFB1
3positive regulation of collagen biosynthetic processGO:003296710.1CCL2, TGFB1
4negative regulation of myoblast differentiationGO:004566210.0MSTN, TGFB1
5cellular response to organic cyclic compoundGO:007140710.0CCL2, TGFB1
6organ regenerationGO:003110010.0CCL2, TGFB1
7positive regulation of superoxide anion generationGO:003293010.0SOD1, TGFB1
8positive regulation of pathway-restricted SMAD protein phosphorylationGO:00108629.9MSTN, TGFB1
9cellular response to drugGO:00356909.9CCL2, NOS2
10growthGO:00400079.9MSTN, TGFB1
11response to progesteroneGO:00325709.9CCL2, TGFB1
12response to woundingGO:00096119.9CCL2, TGFB1
13negative regulation of angiogenesisGO:00165259.8CCL2, DCN
14response to bacteriumGO:00096179.8CCL2, NOS2
15lipopolysaccharide-mediated signaling pathwayGO:00316639.8CCL2, TGFB1
16cellular response to interferon-gammaGO:00713469.7CCL2, NOS2
17response to antibioticGO:00466779.6CCL2, SOD1
18inflammatory responseGO:00069549.5IFNA2, NOS2, TGFB1
19superoxide metabolic processGO:00068019.5NOS2, SOD1
20blood coagulationGO:00075969.2IFNA2, SOD1, TGFB1
21response to heatGO:00094089.0CCL2, MSTN
22transforming growth factor beta receptor signaling pathwayGO:00071799.0CCL2, MSTN, TGFB1
23cellular response to dexamethasone stimulusGO:00715498.9CCL2, MSTN, TGFB1
24response to drugGO:00424938.7CCL2, SOD1, TGFB1
25agingGO:00075688.5CCL2, DCN, SOD1, TGFB1

Sources for Peyronie's Disease

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet